Minimal residual disease in gastrointestinal cancer

Seminars in Surgical Oncology

Volumn 20, Issue 4, 2001, Pages 282-293

  Kienle, Peter ^a   Koch, Moritz ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Disseminated tumor cells; Gastrointestinal cancer; Prognostic relevance

Indexed keywords

DIGESTIVE SYSTEM CANCER; DISSEMINATED CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR GROWTH;

GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 0034762486     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.1046     Document Type: Review

References (150)

1. Clinical perspectives on human colorectal cancer metastasis
2. Clinical implications of metastatic process
3. Potential pathological application of immunocytochemical methods to the detection of micrometastasis
4. Minimal residual disease: Detection, clinical relevance and treatment strategies
5. Disseminated tumor cells: Diagnosis, prognostic relevance, phenotyping and therapeutic strategies
6. Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow
7. Bone marrow micrometastasis of epithelial tumors: Detection and clinical relevance
8. Detection and enumeration of circulating tumor cells in colorectal cancer
9. Are micrometastasis clinically relevant?
10. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow
11. Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients
12. The molecular detection of circulating tumor cells
13. Automated detection of occult bone marrow micrometastasis in patients with operable lung carcinoma
14. Genotype/phenotype analysis of low frequency tumor cells using computerized image microscopy
15. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma
16. Analysis of FUSCHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications
17. Detection of SYT-SSXl/2 fusion transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR) is a valuable diagnostic tool in synovial sarcoma
18. Illegitimate transcription: Transcription of any gene in any cell type
19. Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation
20. Immunocytochemical detection of disseminated tumor cells in bone marrow of patients with esophageal carcinoma
21. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia
22. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer
23. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma
24. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma
25. Significance of immunohistochemically demonstrated micrometastases to lymph nodes in esophageal cancer with histologically negative nodes
26. Lymph node micrometastasis and prognosis in patients with esophageal squamous cell carcinoma
27. Clinical significance of lymph node micrometastasis of pNO esophageal squamous cell carcinoma
28. Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer
29. Esophageal cancer: The mode of lymphatic tumor cell spread and its prognostic significance
30. Detection and clinical significance of lymph node metastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma
31. Cytology of peritoneal lavage performed during staging laparoscopy for gastrointestinal malignancies: Is it useful?
32. Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon and stomach
33. Comparative analysis bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR
34. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas
35. Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery
36. Limitations of reverse-transcriptase polymerase chain reaction for detection of micrometastatic epithelial cancer cells in bone marrow
37. Micrometastatic tumor cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance
38. Prognostic significance of tumor cells in bone marrow of gastric cancer patients
39. Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer
40. Prognostic significance of bone marrow micrometastases in patients with gastric cancer
41. Individual development and uPA-receptor expression of disseminated tumor cells in bone marrow: A reference to early systemic disease in solid cancer
42. Occult lymph node metastasis in gastric cancer with submucosal invasion
43. Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence
44. Benefits of D2 lymph node dissection for patients with gastric cancer and pNO and pNl lymph node metastases
45. Detection of gastric cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction
46. Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination
47. Prognostic value of microscopic peritoneal dissemination: Comparison between colon and gastric cancer
48. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker
49. Tumorzelldissemination in das knochenmark und in die peritonealhöhle
50. Immunocytological detection of micrometastatic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients
51. Immunocytochemically detected free peritoneal tumor cells (FPTC) are a strong prognostic factor in gastric carcinoma
52. Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology
53. Molecular diagnostic detection of free cancer cells in the peritoneal cavity of patients with gastrointestinal and gynecologic malignancies
54. An assay for hepatoma micrometastasis: Albumin expression in peripheral blood from patients with advanced hepatocellular cacinoma (HCC)
55. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma
56. Albumin messenger RNA is not specific for circulating hepatoma cells
57. Quantitation of α-fetoprotein and albumin messenger RNAs in human hepatocellular carcinoma
58. Hematogenous spreading of hepatocellular carcinoma cells: Possible participation in recurrence in the liver
59. Detection of alpha fetoprotein mRNA, an indicator of hematogenous spreading of hepatocellular carcinoma in the circulation
60. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer
61. Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma
62. Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis
63. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery
64. Semiquantitation of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction
65. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: A quantitative analysis
66. Telomerase activity in peripheral blood for diagnosis of hepatoma
67. Development of a multiple-marker RT-PCR assay for detection of micrometastasis of hepatocellular carcinoma
68. Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients
69. Expression of cytokeratin 20 in the blood of patients with disseminated carcinoma of the pancreas, colon, stomach, and lung
70. CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging
71. Immunocytological detection of micrometastatic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients
72. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR
73. Detection of micrometastasis in bone marrow of pancreatic cancer patients
74. Micrometastases in bone marrow: Prognostic indicators for pancreatic cancer
75. Disseminated tumor cells in pancreatic cancer patients detected by immunocytology: A new prognostic factor
76. Adenocarcinoma of the pancreas: Detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay
77. Early lymphatic tumor cell dissemination in pancreatic cancer: Frequency and prognostic significance
78. Immunocytological detection of disseminated cancer cells in the peritoneal cavity and the bone marrow of pancreatic cancer patients
79. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis
80. Circulating malignant cells and fibrinolysis during resection of colorectal cancer
81. Clinical significance of cancer cells in the circulating blood: Two to five year survival
82. Cancer cells in the blood. A five to nine year follow up study
83. Cancer cells in the bloodstream
84. The cytological demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma
85. Detection and enumeration of circulating tumor cells in colorectal cancer
86. Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease
87. Detection of K-ras point mutations in mesenteric venous blood from colorectal cancer patients by enriched polymerase chain reaction and single-strand conformation polymorphism analysis
88. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer
89. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction
90. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction
91. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive cells in peripheral blood
92. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro
93. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction
94. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR
95. Detektion hämatogener tumorzelldissemination kolorektaler karzinome
96. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer
97. Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer
98. Comparative analysis of tumor cell dissemination in mesenteric, central, and peripheral venous blood in patients with colorectal cancer
99. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection
100. Prognostic significance of reverse transcriptase-polymerase chain reaction measurement of carcinoembryonic antigen mRNA levels in tumor drainage blood and peripheral blood of patients with colorectal carcinoma
101. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease
102. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer
103. Molecular tools in the detection of micrometastatic cancer cells-technical aspects and clinical relevance
104. Metastatic inefficiency
105. The biology of human cancer metastasis
106. Macrophages and metastasis: A biological approach to cancer therapy
107. Metastasis: Quantificative analysis of distribution and fate of tumor cell emboli labeled with 1251-iodo-2′-deoxyuridine
108. Prognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients
109. Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies
110. Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance
111. Cytokeratin-positive cells in bone marrow in comparison with other prognostic factors in colon carcinoma
112. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerasechain reaction is related to the stage of disease
113. Detection of micrometastases in colorectal cancer patients by k19 and k20 reversetranscription polymerase chain reaction
114. Prognosis of node positive colon cancer
115. Are micrometastases clinically relevant?
116. Immunocytochemical detection of carcinoembryonic antigen in conventional histopathology specimens
117. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes B colorectal carcinoma: An immunohistochemical study
118. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins
119. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49
120. The prognostic significance of immunohistochemically detected lymph nodes micrometastases in colorectal carcinoma
121. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinoma: An immunohistochemical study
122. Are lymph node micrometastases of any clinical significance in Dukes A and B colorectal cancer?
123. Prognostic significance of perirectal lymph node micrometastases in Dukes B rectal carcinoma: An immunohistochemical study by CAM5.2
124. Lymph node micrometastases do not predict relapse in stage II colon cancer
125. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method
126. Predictive value of genetic diagnosis for cancer micrometastasis
127. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction
128. Micrometastases and survival in stage II colorectal cancer
129. Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer
130. Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer
131. Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer
132. Limitations of the specific reverse transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
133. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow
134. Genetic detection of lymph node micrometastases in patients with colorectal cancer
135. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20
136. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin
137. Detection of circulating tumor cells and nodal metastasis by reverse transcriptase-polymerase chain reaction technique
138. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes
139. Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers
140. Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer
141. Guanyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer
142. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging
143. Validation of lymphatic mapping in colorectal cancer: In vivo, ex vivo, and laparoscopic techniques
144. Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial
145. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer
146. Abnormal expression of cd44 variants in the exfoliated cells in the feces of patients with colorectal cancer
147. Identification of subjects at risk for colorectal carcinoma through a test based on k-ras determination in the stool
148. Detection of k-ras mutations in stools of patients with colorectal cancer by mutantenriched PCR
149. Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer